Mohamed Abdel-Raheem, Zainab A. SHEHAB

COVID-19 and smoking

• Broschiertes Buch

Produktbeschreibung

There is currently insufficient information to confirm any link between nicotine in the prevention or treatment of COVID-19. WHO urges researchers, scientists and the media to be cautious about amplifying unproven claims that tobacco or nicotine could reduce the risk of COVID-19. WHO is constantly evaluating new research, including that which examines the link between tobacco use, nicotine use, and COVID-19. The harms of tobacco use are well-established. Tobacco causes 8 million deaths every year from cardiovascular diseases, lung disorders, cancers, diabetes, and hypertension. Smoking tobacco is also a known risk factor for severe disease and death from many respiratory infections. In the COVID-19 pandemic, questions have been asked about clinical outcomes for smokers, and whether they are equally susceptible to infection, and if nicotine has any biological effect on the SAR-CoV-2 virus (the virus that causes COVID-19). At the time of writing, one clinical trial to test the effects of nicotine has been announced, but no trial registration record was found as of 12 May 2020.

Produktdetails

• Verlag: LAP Lambert Academic Publishing
• Seitenzahl: 236
• Erscheinungstermin: 10. März 2023
• Englisch
• Abmessung: 220mm x 150mm x 15mm
• Gewicht: 369g
• ISBN-13: 9786206150008
• ISBN-10: 6206150003
• Artikelnr.: 67715945

Autorenporträt

Mohamed Abdel-Raheem Ali Abdel-Raheem, Pests & Plant Protection Department, Agricultural and Biological Research Institute, National Research Centre, Le Caire, Égypte, et Dr. Lamiaa Fingan Nashi Al-Maliki, Department of Molecular and Medical biotechnology, College of Biotechnology, Al-Nahrain University, Bagdad, Iraq.